The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

BMC Cancer (2010) - Comments
pubmed: 20565769 doi: 10.1186/1471-2407-10-298 issn: 1471-2407

Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, Fabrice Journé